Clondalkin Pharma & Healthcare is categorized under in Moorestown, NJ and active since 2012.
Clondalkin Pharma & Healthcare was established in 2012, and today employs 1 to 4, earning $100.000.000 to $499.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact William Mitchell, President at the company’s branch by writing to 1224 North Church St, Moorestown, New Jersey NJ 08057 or by phoning (856) 439-1700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clondalkin Pharma & Healthcare |
| Contact Person: | William Mitchell, President |
| Address: | 1224 North Church St, Moorestown, New Jersey 08057 |
| Phone Number: | (856) 439-1700 |
| Website Address: | clondalkingroup.com |
| Annual Revenue (USD): | $100.000.000 to $499.999.999 |
| Founded: | 2012 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 4242101 |
| Share This Business: |
Clondalkin Pharma & Healthcare was started in 2012 to provide professional under the SIC code 2834 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000.000 to $499.999.999 per annum.
Feel free to contact William Mitchell, President for inquiries that concern Clondalkin Pharma & Healthcare by calling the company number (856) 439-1700, as your correspondence is most welcome. Additionally, the physical location of the branch of Clondalkin Pharma & Healthcare can be found at the coordinates 39.97311,-74.97553 as well as the street address 1224 North Church St in Moorestown, New Jersey 08057.
For its online presence, you may visit Clondalkin Pharma & Healthcare’s website at clondalkingroup.com and engage with its social media outlets through on Twitter and on Facebook.